Italian Cell Diagnostics Company CellPly Seeded with €2M
March 21, 2014
Italy-based molecular diagnostics company CellPly has secured a €2 million ($2.8 million) seed investment from Italian Angels for Growth, Zernike META Ventures and Atlante Seed. The investment will contribute to the completion of the prototyping phase of CellPly's diagnostics platform. The company's technology platform is designed to help verify cellular response to anti-tumor drugs in-vitro (rather than directly in the patient), assisting the decisions of oncologists and doctors with predictive data.